The global heart valve devices market size was valued at USD 11.63 Billion in 2025, driven by the increasing incidence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 12.90% during the forecast period of 2026-2035 to achieve a value of USD 39.13 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
12.9%
Value in USD Billion
2026-2035
*this image is indicative*
A heart valve is a one-way valve that allows blood to pass through the heart only in one direction. In a mammalian heart, the four valves are frequently represented to show the blood flow pattern through the heart. Depending on the blood pressure differences on each side, a heart valve may open or close as needed. The valves occasionally fail to open or seal precisely. This happens when the blood flow from the heart to the rest of the body is obstructed. It is also known as heart valve disease, and the course of treatment for this condition varies on the heart valve in question as well as the type and degree of the disease.
The global market for heart valve devices is experiencing a surge in growth driven by several key trends. The key trends in the market include increased investments by the key players in the market. For example, Xeltis' successful fundraising is propelling the development of advanced restorative cardiovascular devices. Xeltis, a pioneering medical technology company, is a leader in heart valve replacement and vascular therapies, with the aim of providing patients worldwide access to cutting-edge treatments.
Furthermore, increased research and development activities focused on finding optimal treatments for cardiovascular diseases are significantly proeplling the global heart valve replacement market growth as well. The newly launched products by the key players in the market are also enhancing the market value. For example, minimally invasive procedures like the EVOQUE tricuspid valve replacement system shorten patient recovery times and improve outcomes. This investigational device offers a less invasive alternative to open-heart surgery, showcasing the relentless pursuit of innovative solutions in cardiovascular care.
Additionally, the increased number of clinical trials conducted by key players is further fueling the market growth. For example, Abbott highlights the commitment to advancing treatment options. Abbott's successful clinical trial involving tricuspid valve clipping demonstrates the continuous efforts to enhance patient outcomes and reduce risks.
In conclusion, these market trends collectively contribute to the robust global heart valve devices market growth.
Heart Valve Devices Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Treatment
Market Breakup by End User
Market Breakup by Region
The market is experiencing robust growth driven by the rising number of various heart diseases worldwide, with coronary heart disease being a significant contributor to cardiovascular-related mortality. This prevalence emphasizes the growing demand for advanced heart valve devices to address these conditions. Additionally, there is a substantial shift in preference toward minimally invasive treatment strategies, particularly for complex heart disorders like mitral regurgitation. This shift aligns with the increasing advancements in technology, leading to the development of exceptional products in the market. Continuous innovation in valve technologies by medical device manufacturers is creating new opportunities for the market, further propelling the global heart valve devices market growth.
Geographically, North America is currently leading the regional market and is expected to lead the market in the coming years as well. The region has the presence of a robust healthcare system and key market players. The market is further driven by increased awareness among people regarding the benefits of minimally invasive procedures and robot-assisted surgeries. These drivers collectively contribute to the thriving global heart valve devices market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 11.63 Billion in 2025, driven by increased advancements.
The market is anticipated to grow at a CAGR of 12.90% during the forecast period of 2026-2035 and is likely to reach a market value of USD 39.13 Billion by 2035.
The increasing incidence of cardiovascular diseases is a major factor driving the market growth.
Increasing heavy investments by the key players is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various product types include mechanical heart valves, biological heart valves, and transcatheter valves.
Heart valve devices are used in open surgery and minimally invasive surgery (MIS).
End users in the market are hospitals, speciality clinics, and home healthcare, among others.
Key players involved in the market are AgaMatrix Holdings LLC, Coloplast Corp, 3M Co., Cardinal Health, ConvaTec Inc., B. Braun Melsungen AG, SMITH & NEPHEW, Convatec Group PLC, Medline Industries, Integra Lifesciences Corp., Dermarite Industries, LLC, Amerx Health Care Corp., and Mckesson Corporation.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Treatment |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share